Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Xenotransplantation, where do we stand?

Emanuele Cozzi1, Ermanno Ancona

  • 1Health Unit, Padua General Hospital, Padua, Italy. emanuele.cozzi@unipd.it

Journal of Nephrology
|January 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

The Sex of Donor and Recipients in Solid Organ Transplantation: An in Depth Analysis Across the Council of Europe Member States.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Breaking Barriers: Proof of Concept for Selective Coronary Endothelial Decellularization in Whole Porcine Hearts for Xenotransplantation.

Xenotransplantation·2026
Same author

Pathologic evaluation of pig kidney and heart xenografts: 2024 recommendations from the Banff Xenotransplantation Pathology Working Group.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Autoantibody Profiling in Cardiomyopathies: Toward Immune-Guided Risk Stratification and Therapy.

Journal of clinical medicine·2026
Same author

From transplant rejection to coronary no-reflow: an immune-ischemic framework for antibody-mediated microvascular dysfunction.

American journal of physiology. Heart and circulatory physiology·2026
Same journal

Correction to: Abdominal arterial calcification profile in kidney transplant candidates: a comparison between patients with autosomal dominant polycystic kidney disease and those with other causes of kidney failure.

Journal of nephrology·2026
Same journal

Lessons for the Clinical Nephrologist. Not to see the forest for the trees: the diagnostic challenge with valproic acid-induced Fanconi-like proximal tubulopathy.

Journal of nephrology·2026
Same journal

Longitudinal trajectories in multidomain frailty among patients with chronic kidney disease.

Journal of nephrology·2026
Same journal

Correction to: Association between primary care physician-nephrologist collaboration and clinical outcomes in patients with stage 5 chronic kidney disease: a JOINT-KD cohort study.

Journal of nephrology·2026
Same journal

Improving eGFR estimation in diabetic populations: insights from real-world data.

Journal of nephrology·2026
Same journal

Barriers delaying treatment in cases at risk of crush syndrome in major disasters: Kahramanmaraş earthquake experience.

Journal of nephrology·2026
See all related articles

Xenotransplantation using genetically-engineered pig organs shows promise for human organ shortages. However, significant immunological and zoonotic hurdles remain, preventing immediate clinical trials.

Area of Science:

  • Transplantation immunology
  • Genetically engineered animals
  • Zoonosis research

Background:

  • Global shortage of human organs for transplantation.
  • Xenotransplantation using pig organs is a potential solution.
  • Recent decade has seen significant advances in the field.

Purpose of the Study:

  • To review progress in xenotransplantation as a solution for organ shortages.
  • To elucidate immunological mechanisms of pig-to-primate organ rejection.
  • To assess zoonotic risks, including porcine endogenous retroviruses.

Main Methods:

  • Review of immunological mechanisms in xenotransplantation.
  • Generation of genetically modified pigs for improved compatibility.
  • Assessment of zoonotic risks associated with porcine endogenous retroviruses.

Related Experiment Videos

Main Results:

  • Advances in understanding xenograft rejection in primates.
  • Development of genetically engineered pigs with enhanced compatibility.
  • Improved understanding of porcine endogenous retrovirus transmission risks.

Conclusions:

  • Despite advances, preclinical data are insufficient for human clinical trials.
  • Human organ transplantation remains the current standard for organ failure.
  • Further research is needed to overcome immunological and safety barriers.